We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$137M
AUM Growth
+$16.5M
Cap. Flow
+$772K
Cap. Flow %
0.56%
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34

Top Buys

Rank Stock Value
1
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
+$3.12M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$3.04M
3
MXIM
Maxim Integrated Products
MXIM
+$2.88M
4
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$2.01M
5
STRO icon
Sutro Biopharma
STRO
+$611K

Top Sells

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$7.91M
2
CZR
Caesars Entertainment Corporation
CZR
+$4.15M
3
LOGM
LogMein, Inc.
LOGM
+$2.89M
4
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$548K
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$505K

Sector Composition

Rank Sector Weight
1 Technology 36.76%
2 Healthcare 21.07%
3 Financials 13.05%
4 Consumer Discretionary 10.17%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
126
PTC Therapeutics
PTCT
$6.15B
– –
-8,198
Closed -$416K
RYTM icon
127
Rhythm Pharmaceuticals
RYTM
$7.77B
– –
-18,609
Closed -$415K
SACH
128
Sachem Capital Corp
SACH
$39M
– –
-12,500
Closed -$37K
SCCO icon
129
Southern Copper
SCCO
$164B
– –
-7,205
Closed -$262K
SRPT icon
130
Sarepta Therapeutics
SRPT
$1.92B
– –
-2,570
Closed -$412K
TIMB icon
131
TIM SA
TIMB
$8.62B
– –
-11,300
Closed -$146K
VSTM icon
132
Verastem
VSTM
$638M
– –
-20,588
Closed -$425K
PVLA
133
Palvella Therapeutics
PVLA
$2.22B
– –
-335
Closed -$83K
BCEL
134
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-15,330
Closed -$326K
SGEN
135
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-2,549
Closed -$433K
RVLP
136
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-11,800
Closed -$79K
SI
137
DELISTED
Silvergate Capital Corporation
SI
– –
-13,579
Closed -$190K
JNCE
138
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-15,000
Closed -$104K
TCDA
139
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-16,235
Closed -$446K
ATHX
140
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-752
Closed -$52K
EIDX
141
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-10,596
Closed -$505K
MNTA
142
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-11,266
Closed -$375K
PRNB
143
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-9,165
Closed -$548K
LOGM
144
DELISTED
LogMein, Inc.
LOGM
– –
-34,109
Closed -$2.89M
TECD
145
DELISTED
Tech Data Corp
TECD
– –
-54,600
Closed -$7.91M
PDLI
146
DELISTED
PDL BioPharma, Inc.
PDLI
– –
-12,700
Closed -$37K
CZR
147
DELISTED
Caesars Entertainment Corporation
CZR
– –
-342,418
Closed -$4.15M
2 3 4 5
6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2020 Portfolio in Review

As of Q3 2020, HighVista Strategies held 147 positions worth $137M, up 14% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HighVista Strategies's Q3 2020 filing shows 47 new, 29 increased, 15 reduced and 34 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M. The largest sale was Tech Data Corp, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q3 2020 buy was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M.
  • HighVista Strategies added most to Xenon Pharmaceuticals in Q3 2020, an estimated $274K increase.
  • HighVista Strategies's biggest Q3 2020 reduction was Kadmon Holdings, Inc., cutting an estimated $256K.
  • HighVista Strategies fully exited Tech Data Corp in Q3 2020, selling an estimated $7.91M.
  • HighVista Strategies's ten largest holdings make up 69% of its $137M portfolio in Q3 2020.
  • HighVista Strategies opened 47 new positions and closed 34 in Q3 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $137M.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.